Haviland Kate

Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: $0

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
FULC	Fulcrum Therapeutics, Inc.	$0	$0	$0	—	Jun 30
BCAX	Bicara Therapeutics Inc.	$0	$0	$0	—	Jun 9
AVLN	Avalyn Pharma Inc.	$0	$0	$0	—	Apr 29
BPMC	Blueprint Medicines Corp	$0	$0	$0	0	Jul 17, 2025

FULC

Fulcrum Therapeutics, Inc.

Bought

Sold

Held

—

BCAX

Bicara Therapeutics Inc.

Bought

Sold

Held

—

AVLN

Avalyn Pharma Inc.

Bought

Sold

Held

—

BPMC

Blueprint Medicines Corp

Bought

Sold

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

All 6 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Trade history

The 18 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Jun 30	FULC	Fulcrum Therapeutics, Inc.	AGRANT◆	32,000	—	—	—	Open the original filing on SEC.gov
Jun 9	BCAX	Bicara Therapeutics Inc.	AGRANT◆	19,475	—	—	—